The endocrinology of gonadal involution: Menopause and andropause

Annales d'Endocrinologie

Volumn 64, Issue 2, 2003, Pages 77-81

  Lamberts, S W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; TESTOSTERONE;

AGING; ANDROPAUSE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG INDUCED DISEASE; ESTROGEN SYNTHESIS; FEMALE; GONAD FUNCTION; HORMONE SUBSTITUTION; HUMAN; MALE; MENOPAUSE; OVARY; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; AGING; BONE DENSITY; CARDIOVASCULAR DISEASES; DEMENTIA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; EXERCISE; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MENOPAUSE; MIDDLE AGED; MUSCLE, SKELETAL; OVARY; RANDOMIZED CONTROLLED TRIALS; TESTIS; TESTOSTERONE;

EID: 0037651287     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Rowe JW, Kahn RL. Human aging: usual and successful. Science 1987; 237: 143-9.
2. Manton KG, Gu X. Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999. Proc Natl Acad Sci U S A 2001; 98: 6354-9.
3. Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science 1997; 278: 419-24.
4. Barrett-Connor E, Stuenkel CA. Hormone replacement therapy (HRT) - risks and benefits. Int J Epidemiol 2001; 30: 423-6.
5. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Jama 2002; 288: 321-33.
6. Laine C. Postmenopausal hormone replacement therapy: how could we have been so wrong? Ann Intern Med 2002; 137: 290.
7. Petitti DB. Hormone replacement therapy for prevention: more evidence, more pessimism. Jama 2002; 288: 99-101.
8. Stevenson JC, Whitehead MI. Hormone replacement therapy. Bmj 2002; 325: 113-4.
9. Herrington DM, Howard TD, Hawkins GA, et al. Estrogenreceptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 2002; 346: 967-74.
10. Gerhardt A, Scharf RE, Beckmann MW, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000; 342: 374-80.
11. De Stefano V, Martinelli I, Mannucci PM, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 1999; 341: 801-6.
12. Lamberts SW. The endocrinology of aging and the brain. Arch Neurol 2002; 59: 1709-11.
13. Dubal DB, Zhu H, Yu J, et al. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A 2001; 98: 1952-7.
14. Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical time. Jama 2002; 288: 2170-2.
15. LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and metaanalysis. Jama 2001; 285: 1489-99.
16. Asthana S, Baker LD, Craft S, et al. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology 2001; 57: 605-12.
17. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. Jama 2002; 288: 2123-9.
18. Lebrun CE, Van Der Schouw YT, Bak AA, et al. Arterial stiffness in postmenopausal women: determinants of pulse wave velocity. J Hypertens 2002; 20: 2165-72.
19. van der Schouw YT, Pijpe A, Lebrun CE, et al. Higher usual dietary intake of phytoestrogens is associated with lower aortic stiffness in postmenopausal women. Arterioscler Thromb Vasc Biol 2002; 22: 1316-22.
20. Sierksma A LC, Schouw YT van der, Grobbee D, Lamberts SWJ, Hendriks HFJ, Bots ML. Alcohol consumption and aortic stiffness: cross sectional study in healthy postmenopausal women. Arterioscler Thromb Vasc Biol 2003, in press.
21. Blackman MR, Sorkin JD, Munzer T, et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. Jama 2002; 288: 2282-92.
22. Tenover JS. Androgen administration to aging men. Endocrinol Metab Clin North Am 1994; 23: 877-92.
23. Vermeulen A. Clinical review 24: Androgens in the aging male. J Clin Endocrinol Metab 1991; 73: 221-4.
24. Barrett-Connor E, Von Muhlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab 1999; 84: 573-7.
25. Wang C, Swedloff RS, Iranmanesh A, et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone Gel Study Group. J Clin Endocrinol Metab 2000; 85: 2839-53.
26. Bagatell CJ, Bremner WJ. Androgens in men - uses and abuses. N Engl J Med 1996; 334 (11): 707-14.
27. Pearlman CK, Kobashi LI. Frequency of intercourse in men. J Urol 1972; 107: 298-301.
28. Bhasin S, Bremner WJ. Clinical review 85: Emerging issues in androgen replacement therapy. J Clin Endocrinol Metab 1997; 82: 3-8.
29. Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999; 84: 1966-72.
30. Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999; 84: 2647-53.
31. Sih R, Morley JE, Kaiser FE, Perry HM, 3rd, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997; 82: 1661-7.
32. Negro-Vilar A. Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium. J Clin Endocrinol Metab 1999; 84: 3459-62.